CL
Colgate-Palmolive Company NYSE Listed May 2, 1973$87.37
Mkt Cap $70.1B
52w Low $74.55
51.7% of range
52w High $99.33
50d MA $87.41
200d MA $83.86
P/E (TTM)
33.0x
EV/EBITDA
17.8x
P/B
193.3x
Debt/Equity
147.9x
ROE
3948.1%
P/FCF
17.6x
RSI (14)
—
ATR (14)
—
Beta
0.33
50d MA
$87.41
200d MA
$83.86
Avg Volume
6.3M
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
300 Park Avenue · New York City, NY 10022-7499 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | BMO | 0.94 | 0.97 | +2.9% | 85.36 | +3.3% | +2.2% | +0.0% | +1.1% | +3.3% | +2.3% | — |
| Jan 30, 2026 | BMO | 0.91 | 0.95 | +4.2% | 85.24 | +4.1% | +5.9% | +7.8% | +9.3% | +10.7% | +11.3% | — |
| Oct 31, 2025 | BMO | 0.89 | 0.91 | +2.4% | 76.51 | -1.3% | +0.7% | -2.0% | +0.1% | +0.5% | +1.0% | — |
| Aug 1, 2025 | BMO | 0.90 | 0.92 | +2.6% | 83.85 | +0.2% | -0.4% | -0.6% | -0.9% | +0.9% | +1.0% | — |
| Apr 25, 2025 | BMO | 0.86 | 0.91 | +6.3% | 92.70 | +3.0% | +1.3% | -1.9% | -0.4% | -0.6% | -2.2% | — |
| Jan 31, 2025 | BMO | 0.90 | 0.91 | +1.1% | 90.89 | -6.0% | -4.6% | -4.2% | -4.8% | -4.7% | -5.7% | — |
| Oct 25, 2024 | BMO | 0.89 | 0.91 | +2.2% | 99.74 | -3.2% | -4.1% | -4.0% | -5.0% | -5.1% | -6.0% | — |
| Jul 26, 2024 | BMO | 0.87 | 0.91 | +4.6% | 96.49 | +2.6% | +3.0% | +4.5% | +4.1% | +2.8% | +4.6% | — |
| Apr 26, 2024 | BMO | 0.81 | 0.86 | +6.2% | 89.29 | +1.9% | +1.9% | +1.3% | +2.9% | +2.9% | +4.1% | — |
| Jan 26, 2024 | BMO | 0.85 | 0.87 | +2.4% | 81.22 | +0.4% | +2.0% | +3.4% | +3.7% | +3.7% | +6.0% | — |
| Oct 27, 2023 | BMO | 0.80 | 0.86 | +7.5% | 73.08 | +0.3% | -1.8% | +1.1% | +2.8% | +2.5% | +2.4% | — |
| Jul 28, 2023 | BMO | 0.75 | 0.77 | +2.7% | 77.11 | -2.5% | -1.9% | -1.1% | -0.6% | +0.6% | -0.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 | Morgan Stanley | Maintains | Overweight → Overweight | — | $82.35 | $82.70 | +0.4% | +1.7% | +2.8% | +2.2% | +4.0% | +2.6% |
| Apr 21 | Rothschild& Co | Upgrade | Neutral → Buy | — | $83.53 | $84.12 | +0.7% | -2.1% | -1.4% | +0.2% | +1.3% | +0.8% |
| Apr 21 | Rothschild & Co Redburn | Upgrade | Neutral → Buy | $100 | $83.53 | $84.12 | +0.7% | -2.1% | -1.4% | +0.2% | +1.3% | +0.8% |
| Apr 21 | Rothschild & Co | Upgrade | Neutral → Buy | — | $83.53 | $84.12 | +0.7% | -2.1% | -1.4% | +0.2% | +1.3% | +0.8% |
| Apr 17 | JP Morgan | Maintains | Overweight → Overweight | — | $83.62 | $83.70 | +0.1% | +2.6% | -0.1% | -2.2% | -1.5% | +0.1% |
| Apr 14 | Barclays | Maintains | Equal Weight → Equal Weight | — | $83.98 | $83.34 | -0.8% | +0.2% | -0.6% | -0.4% | +2.2% | -0.5% |
| Apr 10 | BofA Securities | Maintains | Buy → Buy | — | $86.04 | $85.95 | -0.1% | -2.0% | -2.4% | -2.2% | -3.0% | -2.8% |
| Apr 8 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $83.13 | $83.75 | +0.7% | +2.9% | +3.5% | +1.5% | +1.0% | +1.2% |
| Apr 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $83.13 | $83.75 | +0.7% | +2.9% | +3.5% | +1.5% | +1.0% | +1.2% |
| Apr 7 | UBS | Maintains | Buy → Buy | — | $84.53 | $84.53 | +0.0% | -1.7% | +1.2% | +1.8% | -0.2% | -0.7% |
| Mar 30 | Deutsche Bank | Upgrade | Hold → Buy | — | $84.29 | $85.52 | +1.5% | +1.7% | +1.1% | +1.3% | +1.0% | +0.3% |
| Feb 3 | Barclays | Maintains | Equal Weight → Equal Weight | — | $91.89 | $90.98 | -1.0% | +1.4% | +2.7% | +3.3% | +2.7% | +2.5% |
| Feb 2 | Jefferies | Maintains | Hold → Hold | — | $90.29 | $90.55 | +0.3% | +1.8% | +3.2% | +4.5% | +5.1% | +4.6% |
| Feb 2 | Piper Sandler | Maintains | Overweight → Overweight | — | $90.29 | $90.55 | +0.3% | +1.8% | +3.2% | +4.5% | +5.1% | +4.6% |
| Feb 2 | JP Morgan | Maintains | Overweight → Overweight | — | $90.29 | $90.55 | +0.3% | +1.8% | +3.2% | +4.5% | +5.1% | +4.6% |
| Feb 2 | BofA Securities | Maintains | Buy → Buy | — | $90.29 | $90.55 | +0.3% | +1.8% | +3.2% | +4.5% | +5.1% | +4.6% |
| Feb 2 | Deutsche Bank | Maintains | Hold → Hold | — | $90.29 | $90.55 | +0.3% | +1.8% | +3.2% | +4.5% | +5.1% | +4.6% |
| Feb 2 | Morgan Stanley | Maintains | Overweight → Overweight | — | $90.29 | $90.55 | +0.3% | +1.8% | +3.2% | +4.5% | +5.1% | +4.6% |
| Feb 2 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $90.29 | $90.55 | +0.3% | +1.8% | +3.2% | +4.5% | +5.1% | +4.6% |
| Feb 2 | Citigroup | Maintains | Buy → Buy | — | $90.29 | $90.55 | +0.3% | +1.8% | +3.2% | +4.5% | +5.1% | +4.6% |
| Feb 2 | Evercore ISI | Maintains | Outperform → Outperform | — | $90.29 | $90.55 | +0.3% | +1.8% | +3.2% | +4.5% | +5.1% | +4.6% |
| Jan 16 | JP Morgan | Maintains | Overweight → Overweight | — | $84.34 | $84.06 | -0.3% | +0.2% | +1.3% | +0.5% | +1.7% | +2.8% |
| Jan 14 | UBS | Maintains | Buy → Buy | — | $82.96 | $83.10 | +0.2% | +1.9% | +1.7% | +1.9% | +3.0% | +2.1% |
| Jan 13 | Wells Fargo | Upgrade | Underweight → Equal Weight | — | $81.93 | $82.36 | +0.5% | +1.3% | +3.2% | +2.9% | +3.2% | +4.3% |
| Jan 8 | TD Cowen | Maintains | Buy → Buy | — | $77.09 | $77.79 | +0.9% | +4.9% | +5.7% | +6.3% | +7.6% | +9.7% |
| Jan 7 | Piper Sandler | Upgrade | Neutral → Overweight | — | $77.20 | $77.89 | +0.9% | -0.1% | +4.8% | +5.5% | +6.1% | +7.5% |
| Dec 18 | JP Morgan | Maintains | Overweight → Overweight | — | $79.73 | $79.41 | -0.4% | -2.5% | -1.7% | -0.9% | +0.3% | +0.7% |
| Dec 11 | Argus | Downgrade | Buy → Hold | — | $77.76 | $77.84 | +0.1% | -0.7% | +0.7% | +2.1% | +1.5% | +2.5% |
| Dec 9 | RBC Capital | Upgrade | Sector Perform → Outperform | — | $76.11 | $76.95 | +1.1% | +1.1% | +2.2% | +1.5% | +2.9% | +4.4% |
| Nov 4 | Barclays | Maintains | Equal Weight → Equal Weight | — | $74.98 | $75.80 | +1.1% | +2.1% | +2.6% | +3.1% | +5.0% | +4.7% |
| Nov 3 | UBS | Maintains | Buy → Buy | — | $77.05 | $76.57 | -0.6% | -2.7% | -0.6% | -0.2% | +0.3% | +2.2% |
| Nov 3 | Morgan Stanley | Maintains | Overweight → Overweight | — | $77.05 | $76.57 | -0.6% | -2.7% | -0.6% | -0.2% | +0.3% | +2.2% |
| Nov 3 | JP Morgan | Maintains | Overweight → Overweight | — | $77.05 | $76.57 | -0.6% | -2.7% | -0.6% | -0.2% | +0.3% | +2.2% |
| Nov 3 | Evercore ISI | Maintains | Outperform → Outperform | — | $77.05 | $76.57 | -0.6% | -2.7% | -0.6% | -0.2% | +0.3% | +2.2% |
| Nov 3 | Wells Fargo | Maintains | Underweight → Underweight | — | $77.05 | $76.57 | -0.6% | -2.7% | -0.6% | -0.2% | +0.3% | +2.2% |
| Nov 3 | Citigroup | Maintains | Buy → Buy | — | $77.05 | $76.57 | -0.6% | -2.7% | -0.6% | -0.2% | +0.3% | +2.2% |
| Oct 20 | Raymond James | Maintains | Outperform → Outperform | — | $79.12 | $79.23 | +0.1% | -0.5% | -0.6% | +0.9% | -0.9% | -1.4% |
| Oct 10 | JP Morgan | Maintains | Overweight → Overweight | — | $77.81 | $78.04 | +0.3% | +0.2% | -1.1% | +0.8% | -0.2% | +0.3% |
| Oct 8 | UBS | Maintains | Buy → Buy | — | $79.11 | $78.94 | -0.2% | -1.4% | -1.6% | -1.5% | -2.7% | -0.9% |
| Oct 8 | BofA Securities | Maintains | Buy → Buy | — | $79.11 | $78.94 | -0.2% | -1.4% | -1.6% | -1.5% | -2.7% | -0.9% |
| Oct 2 | Goldman Sachs | Maintains | Buy → Buy | — | $79.01 | $78.60 | -0.5% | -0.9% | -1.3% | -2.0% | +0.1% | -1.3% |
| Oct 1 | Barclays | Maintains | Equal Weight → Equal Weight | — | $79.94 | $80.25 | +0.4% | -1.2% | -2.0% | -2.4% | -3.1% | -1.0% |
| Sep 25 | Wells Fargo | Maintains | Underweight → Underweight | — | $81.13 | $81.26 | +0.2% | -1.8% | -1.9% | -0.9% | -1.5% | -2.6% |
| Aug 4 | JP Morgan | Maintains | Overweight → Overweight | — | $83.51 | $83.39 | -0.1% | -0.2% | -0.5% | +1.3% | +1.4% | +1.4% |
| Aug 4 | Wells Fargo | Maintains | Underweight → Underweight | — | $83.51 | $83.39 | -0.1% | -0.2% | -0.5% | +1.3% | +1.4% | +1.4% |
| Aug 4 | Morgan Stanley | Maintains | Overweight → Overweight | — | $83.51 | $83.39 | -0.1% | -0.2% | -0.5% | +1.3% | +1.4% | +1.4% |
| Aug 4 | Citigroup | Maintains | Buy → Buy | — | $83.51 | $83.39 | -0.1% | -0.2% | -0.5% | +1.3% | +1.4% | +1.4% |
| Jul 25 | JP Morgan | Maintains | Overweight → Overweight | — | $88.45 | $88.39 | -0.1% | -0.6% | -2.2% | -1.8% | -3.0% | -5.2% |
| Jul 17 | UBS | Maintains | Buy → Buy | — | $87.66 | $87.66 | +0.0% | -0.5% | -0.9% | -1.2% | +1.2% | +1.3% |
| Jul 15 | Barclays | Maintains | Equal Weight → Equal Weight | — | $88.85 | $88.85 | +0.0% | -0.8% | -1.3% | -1.8% | -2.3% | -2.5% |
No insider trades available.
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Colgate-Palmolive's executive departure may signal internal instability or strategic shifts, potentially affecting investor confidence and near-term stock performance depending on successor quality.
Apr 9
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Colgate-Palmolive disclosed a material announcement requiring cross-reference with its 2025 10-K filing, signaling either significant business developments, strategic changes, or financial impacts that warrant investor review.
Mar 17
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Colgate-Palmolive's CEO is departing the board to lead Kraft Heinz, signaling leadership transition uncertainty at CL while potentially strengthening KHC's management team.
Mar 12
Data updated apr 25, 2026 1:32am
· Source: massive.com